In the last 10 years, the S&P 500 has done historically well for investors, producing an annualized total return of 13.2%.

Trivariate Research has published a list of companies it said are candidates to announce another accelerated share repurchase ...

Shares of Halozyme Therapeutics, Inc. HALO were up 5% on Jan. 8 after the company raised its guidance for 2025. The stock ...

Of all the great rivalries throughout time, whether it be sports or business, or something else, you'd be hard pressed to ...

Halozyme (NASDAQ:HALO) has raised its financial guidance estimates for 2025 based on expected strong sales of products ...

Product Revenues, Net Expected in the Range of $735 Million to $750 Million – – Jornay PM® Net Revenue Expected to be in ...

EST Halozyme (HALO) announces new $250M accelerated share repurchase plan Stay Ahead of the Market:Discover outperforming stocks and ...